BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 26643954)

  • 1. Metabolism pathways in chronic lymphocytic leukemia.
    Rozovski U; Hazan-Halevy I; Barzilai M; Keating MJ; Estrov Z
    Leuk Lymphoma; 2016; 57(4):758-65. PubMed ID: 26643954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aberrant LPL Expression, Driven by STAT3, Mediates Free Fatty Acid Metabolism in CLL Cells.
    Rozovski U; Grgurevic S; Bueso-Ramos C; Harris DM; Li P; Liu Z; Wu JY; Jain P; Wierda W; Burger J; O'Brien S; Jain N; Ferrajoli A; Keating MJ; Estrov Z
    Mol Cancer Res; 2015 May; 13(5):944-53. PubMed ID: 25733697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ibrutinib inhibits free fatty acid metabolism in chronic lymphocytic leukemia.
    Rozovski U; Harris DM; Li P; Liu Z; Jain P; Ferrajoli A; Burger J; Thompson P; Jain N; Wierda W; Keating MJ; Estrov Z
    Leuk Lymphoma; 2018 Nov; 59(11):2686-2691. PubMed ID: 29465264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitochondrial metabolism contributes to oxidative stress and reveals therapeutic targets in chronic lymphocytic leukemia.
    Jitschin R; Hofmann AD; Bruns H; Giessl A; Bricks J; Berger J; Saul D; Eckart MJ; Mackensen A; Mougiakakos D
    Blood; 2014 Apr; 123(17):2663-72. PubMed ID: 24553174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Stromal Microenvironment Modulates Mitochondrial Oxidative Phosphorylation in Chronic Lymphocytic Leukemia Cells.
    Vangapandu HV; Ayres ML; Bristow CA; Wierda WG; Keating MJ; Balakrishnan K; Stellrecht CM; Gandhi V
    Neoplasia; 2017 Oct; 19(10):762-771. PubMed ID: 28863345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elimination of chronic lymphocytic leukemia cells in stromal microenvironment by targeting CPT with an antiangina drug perhexiline.
    Liu PP; Liu J; Jiang WQ; Carew JS; Ogasawara MA; Pelicano H; Croce CM; Estrov Z; Xu RH; Keating MJ; Huang P
    Oncogene; 2016 Oct; 35(43):5663-5673. PubMed ID: 27065330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting metabolism and survival in chronic lymphocytic leukemia and Richter syndrome cells by a novel NF-κB inhibitor.
    Vaisitti T; Gaudino F; Ouk S; Moscvin M; Vitale N; Serra S; Arruga F; Zakrzewski JL; Liou HC; Allan JN; Furman RR; Deaglio S
    Haematologica; 2017 Nov; 102(11):1878-1889. PubMed ID: 28860341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting Mitochondrial Bioenergetics as a Therapeutic Strategy for Chronic Lymphocytic Leukemia.
    Roy Chowdhury S; Banerji V
    Oxid Med Cell Longev; 2018; 2018():2426712. PubMed ID: 29682155
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting lipid metabolism by the lipoprotein lipase inhibitor orlistat results in apoptosis of B-cell chronic lymphocytic leukemia cells.
    Pallasch CP; Schwamb J; Königs S; Schulz A; Debey S; Kofler D; Schultze JL; Hallek M; Ultsch A; Wendtner CM
    Leukemia; 2008 Mar; 22(3):585-92. PubMed ID: 18079738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipoprotein lipase in chronic lymphocytic leukemia: function and prognostic implications.
    Rombout A; Verhasselt B; Philippé J
    Eur J Haematol; 2016 Nov; 97(5):409-415. PubMed ID: 27504855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Important Role of STAT3 in Chronic Lymphocytic Leukaemia Biology.
    Boudny M; Trbusek M
    Klin Onkol; 2020; 33(1):32-38. PubMed ID: 32075387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxidative stress in chronic lymphocytic leukemia: still a matter of debate.
    D'Arena G; Seneca E; Migliaccio I; De Feo V; Giudice A; La Rocca F; Capunzo M; Calapai G; Festa A; Caraglia M; Musto P; Iorio EL; Ruggieri V
    Leuk Lymphoma; 2019 Apr; 60(4):867-875. PubMed ID: 30234409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective Anticancer Activity of Acacetin Against Chronic Lymphocytic Leukemia Using Both In Vivo and In Vitro Methods: Key Role of Oxidative Stress and Cancerous Mitochondria.
    Salimi A; Roudkenar MH; Sadeghi L; Mohseni A; Seydi E; Pirahmadi N; Pourahmad J
    Nutr Cancer; 2016; 68(8):1404-1416. PubMed ID: 27779444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lysosomotropic agents selectively target chronic lymphocytic leukemia cells due to altered sphingolipid metabolism.
    Dielschneider RF; Eisenstat H; Mi S; Curtis JM; Xiao W; Johnston JB; Gibson SB
    Leukemia; 2016 Jun; 30(6):1290-300. PubMed ID: 26859075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low Density Lipoproteins Amplify Cytokine-signaling in Chronic Lymphocytic Leukemia Cells.
    McCaw L; Shi Y; Wang G; Li YJ; Spaner DE
    EBioMedicine; 2017 Feb; 15():24-35. PubMed ID: 27932296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective toxicity of persian gulf sea cucumber holothuria parva on human chronic lymphocytic leukemia b lymphocytes by direct mitochondrial targeting.
    Salimi A; Motallebi A; Ayatollahi M; Seydi E; Mohseni AR; Nazemi M; Pourahmad J
    Environ Toxicol; 2017 Apr; 32(4):1158-1169. PubMed ID: 27404045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The potential anticancer agent PK11195 induces apoptosis irrespective of p53 and ATM status in chronic lymphocytic leukemia cells.
    Santidrián AF; Cosialls AM; Coll-Mulet L; Iglesias-Serret D; de Frias M; González-Gironès DM; Campàs C; Domingo A; Pons G; Gil J
    Haematologica; 2007 Dec; 92(12):1631-8. PubMed ID: 18055986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Organometallic nucleosides induce non-classical leukemic cell death that is mitochondrial-ROS dependent and facilitated by TCL1-oncogene burden.
    Prinz C; Vasyutina E; Lohmann G; Schrader A; Romanski S; Hirschhäuser C; Mayer P; Frias C; Herling CD; Hallek M; Schmalz HG; Prokop A; Mougiakakos D; Herling M
    Mol Cancer; 2015 Jun; 14():114. PubMed ID: 26041471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone marrow stroma-induced resistance of chronic lymphocytic leukemia cells to arsenic trioxide involves Mcl-1 upregulation and is overcome by inhibiting the PI3Kδ or PKCβ signaling pathways.
    Amigo-Jiménez I; Bailón E; Aguilera-Montilla N; Terol MJ; García-Marco JA; García-Pardo A
    Oncotarget; 2015 Dec; 6(42):44832-48. PubMed ID: 26540567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic rewiring beyond Warburg in chronic lymphocytic leukemia: How much do we actually know?
    Galicia-Vázquez G; Aloyz R
    Crit Rev Oncol Hematol; 2019 Feb; 134():65-70. PubMed ID: 30771875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.